Gambling disorder (GD) is a behavioral addiction, in which dysfunctions in prefrontal activity have been proposed as relevant pathophysiological correlates. The aim of the present study was to preliminarily investigate the feasibility of a noninvasive neuromodulation intervention targeting the prefrontal cortex to treat GD in an open-label setting. We included 8 treatment-seeking patients with GD (7 males; 1 female; mean age: 40.6 ± 11.2). The study consisted of 3 phases: (1) outpatient screening phase, (2) 2-week intensive repetitive transcranial magnetic stimulation (rTMS) treatment phase (twice daily, 5 days/week for 2 weeks); and (3) 3-month maintenance follow-up phase (twice daily, once a week). Each high-frequency (15 Hz) rTMS session was delivered targeting the left dorsolateral prefrontal cortex. GD severity and treatment response were assessed at the baseline and during the follow-up. No relevant side effect was reported. We found a 71.2% Gambling Symptom Assessment Scale mean score reduction after 2 weeks of rTMS treatment; the days spent gambling decreased from 19.63 ± 7.96 to 0.13 ± 0.35 days. Clinical improvements were maintained throughout the study period. The lack of a control group limits the interpretation of these results. In conclusion, these results consolidate the rationale that rTMS interventions deserve further investigation as a potential treatment for GD. These protocols should be tested in larger randomized controlled studies, to determine the real benefits of neuromodulation in the clinical course of patients with GD. Registration Number:ClinicalTrials.gov Identifier NCT03336879.

1.
Clark L, Boileau I, Zack M. Neuroimaging of reward mechanisms in Gambling disorder: an integrative review.
Mol Psychiatry
. 2019 May;24(5):674–93.
2.
Moccia L, Pettorruso M, De Crescenzo F, De Risio L, di Nuzzo L, Martinotti G, et al. Neural correlates of cognitive control in gambling disorder: a systematic review of fMRI studies.
Neurosci Biobehav Rev
. 2017 Jul;78:104–16.
3.
Schluter RS, Daams JG, van Holst RJ, Goudriaan AE. Effects of Non-invasive Neuromodulation on Executive and Other Cognitive Functions in Addictive Disorders: A Systematic Review.
Front Neurosci
. 2018 Sep;12:642.
4.
Hadar A, Zangen A. Brain Stimulation as a Novel Technique for Craving Management and the Treatment of Addiction. In: WIlson SJ, editor.
The Wiley Handbook on the Cognitive Neuroscience of Addiction
. John Wiley & Sons, Ltd; 2015. pp. 357–89.
5.
Pettorruso M, Spagnolo PA, Leggio L, Janiri L, Di Giannantonio M, Gallimberti L, et al. Repetitive transcranial magnetic stimulation of the left dorsolateral prefrontal cortex may improve symptoms of anhedonia in individuals with cocaine use disorder: A pilot study.
Brain Stimul
. 2018 Sep - Oct;11(5):1195–7.
6.
Gay A, Boutet C, Sigaud T, Kamgoue A, Sevos J, Brunelin J, et al. A single session of repetitive transcranial magnetic stimulation of the prefrontal cortex reduces cue-induced craving in patients with gambling disorder.
Eur Psychiatry
. 2017 Mar;41:68–74.
7.
Pettorruso M, Di Giuda D, Martinotti G, Cocciolillo F, De Risio L, Montemitro C, et al.; NST Study Group. Dopaminergic and clinical correlates of high-frequency repetitive transcranial magnetic stimulation in gambling addiction: a SPECT case study.
Addict Behav
. 2019 Jun;93:246–9.
8.
Rosenberg O, Klein LD, Dannon PN. Deep transcranial magnetic stimulation for the treatment of pathological gambling.
Psychiatry Res
. 2013 Mar;206(1):111–3.
9.
Sauvaget A, Bulteau S, Guilleux A, Leboucher J, Pichot A, Valriviere P, et al. Both active and sham low-frequency rTMS single sessions over the right DLPFC decrease cue-induced cravings among pathological gamblers seeking treatment: A randomized, double-blind, sham-controlled crossover trial.
J Behav Addict
. 2018 Mar;7(1):126–136.
10.
Zack M, Cho SS, Parlee J, Jacobs M, Li C, Boileau I, et al. Effects of High Frequency Repeated Transcranial Magnetic Stimulation and Continuous Theta Burst Stimulation on Gambling Reinforcement, Delay Discounting, and Stroop Interference in Men with Pathological Gambling.
Brain Stimul
. 2016 Nov - Dec;9(6):867–75.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.